Eric G. Marcusson

8.1k citations

47 papers · 4.9k indexed · 2 hit papers · h-index 30

Molecular Biology top 2%
Cancer Research top 0.5%
Cell Biology top 1%
Oncology top 5%
Immunology top 10%

Co-authors: Scott D. Emr Joan Lin Cereghino Nicholas M. Dean Balkrishen Bhat Bruce Horazdovsky Editte Gharakhanian Matthew Seaman Elizabeth Pan
Topics: MicroRNA in disease regulation (18 papers)RNA Interference and Gene Delivery (15 papers)Circular RNAs in diseases (9 papers)
Cited by: Cancer Research Molecular Biology Cell Biology
Journals: Cell Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United States Denmark Japan

In The Last Decade

Eric G. Marcusson

47 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MicroRNA-143 Regulates Adipocyte Differentiation

2004 831 citations Christine Esau, Xiaolin Kang et al. Journal of Biological Chemistry profile →
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

2010 608 citations Li Ma, Ferenc Reinhardt et al. Nature Biotechnology profile →

Peers

Countries citing papers authored by Eric G. Marcusson

Since Specialization

Citations

This map shows the geographic impact of Eric G. Marcusson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric G. Marcusson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric G. Marcusson more than expected).

Fields of papers citing papers by Eric G. Marcusson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric G. Marcusson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric G. Marcusson. The network helps show where Eric G. Marcusson may publish in the future.

Co-authorship network of co-authors of Eric G. Marcusson

This figure shows the co-authorship network connecting the top 25 collaborators of Eric G. Marcusson. A scholar is included among the top collaborators of Eric G. Marcusson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric G. Marcusson. Eric G. Marcusson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase I randomized, observer-blinded, placebo-controlled study of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B 2023 ·Scientific Reports ·Natalia Martín‐Orozco,Noah Vale,(unknown),(unknown),Lawrence T. Reiter,Yuko Arita,Reuben Samson,Queenie Hu,Anne‐Claude Gingras,(unknown),Eric G. Marcusson,Piyush M. Patel	5
2	Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept 2015 ·Journal of Neuro-Oncology ·Bo Halle,Eric G. Marcusson,Charlotte Aaberg-Jessen,Stine Skov Jensen,Morten Meyer,Mette Katrine Schulz,Claus L. Andersen,Bjarne Winther Kristensen	22
3	Anti-miRs Competitively Inhibit microRNAs in Argonaute Complexes 2014 ·PLoS ONE ·Daniel J. Hogan,Thomas M. Vincent,Sarah Fish,Eric G. Marcusson,Balkrishen Bhat,B. Nelson Chau,Dimitrios G. Zisoulis	39
4	Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/ Neu , EGF, and TNF-α in Breast Cancer 2013 ·Cancer Research ·Lianjin Jin,Oliver Wessely,Eric G. Marcusson,Cristina Ivan,George A. Călin,Suresh K. Alahari	150
5	Antisense Inhibition of Survivin Expression as a Cancer Therapeutic 2011 ·Molecular Cancer Therapeutics ·Rosa A. Carrasco,Nancy B. Stamm,Eric G. Marcusson,George Sandusky,Philip W. Iversen,Bharvin K.R. Patel	102
6	Control of RNA processing by a large non-coding RNA over-expressed in carcinomas 2011 ·FEBS Letters ·Rui Lin,(unknown),Chris Black,Andrew T. Watt,Eric G. Marcusson,Susan M. Freier,Thomas S. Edgington	69
7	hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma Therapy 2010 ·Cancer Research ·Eran Elyakim,Einat Sitbon,Alexander Faerman,Sarit Tabak,(unknown),(unknown),Avital Dov,Eric G. Marcusson,C. Frank Bennett,Ayelet Chajut,Dalia Cohen,Noga Yerushalmi	126
8	Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model 2010 ·PMC ·Ferenc Reinhardt,Elizabeth Pan,Jürgen Soutschek,Balkrishen Bhat,Eric G. Marcusson,Julie Teruya‐Feldstein,George W. Bell,Li Ma,Robert A. Weinberg	33
9	Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelbreakdown → 2010 ·Nature Biotechnology ·Li Ma,Ferenc Reinhardt,Elizabeth Pan,Jürgen Soutschek,Balkrishen Bhat,Eric G. Marcusson,Julie Teruya‐Feldstein,George W. Bell,Robert A. Weinberg	608
10	Efficient in vivo microRNA targeting of liver metastasis 2010 ·Oncogene ·(unknown),Miguel F. Segura,Avital Gaziel‐Sovran,Sílvia Menéndez,Farbod Darvishian,Luis Chiriboga,Brandi Levin,Daniel Meruelo,Iman Osman,Jiří Zavadil,Eric G. Marcusson,Eva Hernando	86
11	Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma Cells 2007 ·Cancer Research ·Youngsoo Kim,Joon Won Yoon,Xiaokun Xiao,Nicholas M. Dean,Brett P. Monia,Eric G. Marcusson	91
12	Up-regulation of soluble RANKL at tumor-bone interface is critical for mammary tumor-induced osteolysis 2007 ·Cancer Research ·Kalyan C. Nannuru,Mitsuru Futakuchi,Thomas J. Wilson,Rakesh K. Singh,Michelle L. Varney,Thomas M. Vincent,Eric G. Marcusson	2
13	High-Content Imaging Analysis of the Knockdown Effects of Validated siRNAs and Antisense Oligonucleotides 2007 ·SLAS DISCOVERY ·Jonathan Low,Shuguang Huang,Michele Dowless,Wayne Blosser,Thomas M. Vincent,Scott Davis,(unknown),Erich Koller,Eric G. Marcusson,Kerry Blanchard,Louis F. Stancato	14
14	Identification of novel PPARγ target genes in primary human adipocytes 2005 ·Gene ·Ranjan J. Perera,Eric G. Marcusson,Seongjoon Koo,Xiaolin Kang,Youngsoo Kim,Neill White,Nicholas M. Dean	55
15	MicroRNA-143 Regulates Adipocyte Differentiationbreakdown → 2004 ·Journal of Biological Chemistry ·Christine Esau,Xiaolin Kang,Eigen Peralta,Elaine Hanson,Eric G. Marcusson,Lingamanaidu V. Ravichandran,(unknown),Seongjoon Koo,Ranjan J. Perera,Ravi Jain,Nicholas M. Dean,Susan M. Freier,C. Frank Bennett,Bridget Lollo,Richard H. Griffey	831
16	Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage 2004 ·Oncogene ·Jorg Michels,Jason O’Neill,(unknown),(unknown),Fay Habens,Matthew Brimmell,Kam Y. J. Zhang,Ruth W. Craig,Eric G. Marcusson,Peter Johnson,Graham Packham	122
17	Preclinical and Clinical Pharmacology of Antisense Oligonucleotides 1999 ·Molecular Biotechnology ·Eric G. Marcusson,Bruce Yacyshyn,William Shanahan,Nicholas M. Dean	30
18	The cytoplasmic tail domain of the vacuolar protein sorting receptor Vps10p and a subset of VPS gene products regulate receptor stability, function, and localization. 1995 ·Molecular Biology of the Cell ·Joan Lin Cereghino,Eric G. Marcusson,Scott D. Emr	139
19	The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene 1994 ·Cell ·Eric G. Marcusson,Bruce Horazdovsky,Joan Lin Cereghino,Editte Gharakhanian,Scott D. Emr	421
20	Early occurrence of end-stage renal disease in a patient with infantile nephropathic cystinosis 1992 ·The Journal of Pediatrics ·Harold W. Schnaper,(unknown),Suzanne B. Merrill,Eric G. Marcusson,John M. Kissane,Gary D. Shackelford,Samuel So,Raoul D. Nelson,(unknown),Margaret L. Smith,Jerry A. Schneider	9

About Eric G. Marcusson

Eric G. Marcusson is a scholar working on Cancer Research, Molecular Biology and Cell Biology, having authored 47 papers that have together received 4.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (18 papers), RNA Interference and Gene Delivery (15 papers) and Circular RNAs in diseases (9 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (3.8k citations) and Cell Biology (816 citations). Eric G. Marcusson has collaborated with scholars based in United States, Denmark and Japan. Frequent co-authors include Scott D. Emr, Joan Lin Cereghino, Nicholas M. Dean, Balkrishen Bhat, Bruce Horazdovsky, Editte Gharakhanian, Matthew Seaman, Elizabeth Pan, Robert A. Weinberg and George W. Bell. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact